Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102522562 | 10252256 | 2 | F | 201104 | 20160627 | 20140623 | 20160705 | EXP | US-ROCHE-1418176 | ROCHE | 68.24 | YR | F | Y | 0.00000 | 20160705 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 102522562 | 10252256 | 1 | PS | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 500MG QD X 3 DAYS, 500MG BID X 3 WEEK, 1000MG BID | U | 50723 | 500 | MG | TABLET | QD | |||||
| 102522562 | 10252256 | 2 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Unknown | 28 NG/KG/MIN | M362 | 0 | |||||||||
| 102522562 | 10252256 | 3 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 28 NG/KG/MIN | M362 | 0 | INFUSION | ||||||||
| 102522562 | 10252256 | 4 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 28 NG/KG/MIN | M362 | 0 | INFUSION | ||||||||
| 102522562 | 10252256 | 5 | SS | FLOLAN | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | 28 NG/KG/MIN | M362 | 0 | |||||||||
| 102522562 | 10252256 | 6 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | U | 0 | 200 | MG | TABLET | QD | ||||||
| 102522562 | 10252256 | 7 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 8 | C | CLARITIN | LORATADINE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 9 | C | OCUVITE PRESERVISION | 2 | 0 | |||||||||||||
| 102522562 | 10252256 | 10 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 11 | C | ADCIRCA | TADALAFIL | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 12 | C | TRACLEER | BOSENTAN | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 13 | C | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 14 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 15 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 16 | C | TRAMADOL HCL | TRAMADOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 17 | C | TRIAMCINOLONE ACETONIDE. | TRIAMCINOLONE ACETONIDE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 18 | C | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 19 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 20 | C | IMURAN | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 102522562 | 10252256 | 21 | C | BABY ASPIRIN | ASPIRIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 102522562 | 10252256 | 1 | Arthralgia |
| 102522562 | 10252256 | 2 | Cor pulmonale chronic |
| 102522562 | 10252256 | 3 | Pulmonary hypertension |
| 102522562 | 10252256 | 4 | Polymyositis |
| 102522562 | 10252256 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 102522562 | 10252256 | HO |
| 102522562 | 10252256 | LT |
| 102522562 | 10252256 | OT |
| 102522562 | 10252256 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 102522562 | 10252256 | Asthenia | |
| 102522562 | 10252256 | Blood bilirubin increased | |
| 102522562 | 10252256 | Catheter site discharge | |
| 102522562 | 10252256 | Catheterisation cardiac | |
| 102522562 | 10252256 | Complication associated with device | |
| 102522562 | 10252256 | Death | |
| 102522562 | 10252256 | Diarrhoea | |
| 102522562 | 10252256 | Dizziness | |
| 102522562 | 10252256 | Ear infection | |
| 102522562 | 10252256 | Ejection fraction decreased | |
| 102522562 | 10252256 | Flushing | |
| 102522562 | 10252256 | Herpes zoster | |
| 102522562 | 10252256 | Hypertension | |
| 102522562 | 10252256 | Hypoaesthesia | |
| 102522562 | 10252256 | Left ventricular dysfunction | |
| 102522562 | 10252256 | Liver function test increased | |
| 102522562 | 10252256 | Loss of consciousness | |
| 102522562 | 10252256 | Oedema peripheral | |
| 102522562 | 10252256 | Right ventricular heave | |
| 102522562 | 10252256 | Syncope | |
| 102522562 | 10252256 | Tachycardia | |
| 102522562 | 10252256 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 102522562 | 10252256 | 2 | 20100525 | 0 | ||
| 102522562 | 10252256 | 3 | 20120201 | 0 | ||
| 102522562 | 10252256 | 4 | 20110314 | 0 | ||
| 102522562 | 10252256 | 5 | 20100222 | 0 |